10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,487,581 | -58.6% | 60,305 | -43.9% | 0.00% | -50.0% |
| Q2 2023 | $6,004,476 | +952.0% | 107,530 | +951.0% | 0.01% | +500.0% |
| Q1 2023 | $570,787 | -91.9% | 10,231 | -94.7% | 0.00% | -87.5% |
| Q4 2022 | $7,078,725 | +1330.0% | 194,257 | +5610.1% | 0.01% | – |
| Q3 2021 | $495,000 | -92.9% | 3,402 | -90.5% | 0.00% | -100.0% |
| Q2 2021 | $6,998,000 | -57.5% | 35,736 | -60.7% | 0.01% | -62.5% |
| Q1 2021 | $16,455,000 | -43.6% | 90,913 | -55.9% | 0.02% | -38.5% |
| Q4 2020 | $29,172,000 | +64.6% | 206,017 | +45.0% | 0.03% | +44.4% |
| Q3 2020 | $17,720,000 | +2490.6% | 142,119 | +1195.2% | 0.02% | +1700.0% |
| Q1 2020 | $684,000 | +124.3% | 10,973 | +174.1% | 0.00% | – |
| Q4 2019 | $305,000 | – | 4,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |